# Provecta Diagnostics, LLC - Series 14 — Form D

Provecta Diagnostics, LLC - Series 14 of Austin, TX, a company, filed a Form D exempt-offering notice with the SEC on 2018-02-15. The offering totals $20K, of which $20K was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2018-02-15
- Form: D
- Accession: 0001731248-18-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $20K
- Amount sold: $20K
- Minimum investment: $500
- Investors: 2
- Date of first sale: 2018-01-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-305720

## Issuer

- Name: Provecta Diagnostics, LLC - Series 14
- CIK: 0001731248
- Entity type: Other
- Jurisdiction: TEXAS
- Incorporated: 2017
- Address: 2802 Flintrock Trace, Austin, TX, 78738
- Phone: 512-371-4136

## Officers, directors & promoters (1)

| Name | Role | Location |
| --- | --- | --- |
| Robert D Straface | Executive Officer | Austin, TX |

## More

- [CIK 1731248 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1731248&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001731248-18-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.